STERO Ltd., founded in 2017 and headquartered in Israel, is a clinical-stage company committed to the research and development of novel Cannabidiol (CBD) based treatments and solutions that will potentially benefit millions of patients by reducing the side effects and the need of steroid therapy.
STERO’s patent was ISSUED! In the US on August 2018.
The patent exceptional strength is mainly due to its’ extremely wide cove...
STERO Ltd., founded in 2017 and headquartered in Israel, is a clinical-stage company committed to the research and development of novel Cannabidiol (CBD) based treatments and solutions that will potentially benefit millions of patients by reducing the side effects and the need of steroid therapy.
STERO’s patent was ISSUED! In the US on August 2018.
The patent exceptional strength is mainly due to its’ extremely wide coverage. Stero has commenced several clinical trials: our phase 2a clinical trials, on steroid dependent Crohn’s disease (IBD) started on Q1 2020, in Chronic Urticaria (Hives) started on Q3 2020.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.